{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:42:11Z","timestamp":1759405331135,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.03.073","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T14:30:51Z","timestamp":1680705051000},"page":"2961-2967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus vaccination receipt and provider counseling rates among high-risk patients"],"prefix":"10.1016","volume":"41","author":[{"given":"Stephanie M.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma A.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Kazma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten J.H.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"BuAbbud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.03.073_b0010","first-page":"S2","article-title":"The impact of liquid-based cytology in decreasing the incidence of cervical cancer","volume":"4","author":"Gibb","year":"2011","journal-title":"Rev Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0015","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.073_b0020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S1473-3099(16)30120-7","article-title":"Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study","volume":"16","author":"Wheeler","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.03.073_b0025","doi-asserted-by":"crossref","unstructured":"Freedman M, Kroger A, Hunter P, Ault KA, Advisory Committee on Immunization Practices. Recommended Adult Immunization Schedule, United States, 2020. Ann Intern Med. 2020;172(5):337-347. 10.7326\/M20-0046.","DOI":"10.7326\/M20-0046"},{"issue":"32","key":"10.1016\/j.vaccine.2023.03.073_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. US Department of Health and Human Services\/Centers for Disease Control and Prevention","volume":"68","author":"Meites","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0035","article-title":"Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution\u2019s Experience","volume":"8","author":"Petrillo","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.073_b0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women: A Systematic Review and Meta-analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.03.073_b0045","doi-asserted-by":"crossref","first-page":"e070135","DOI":"10.1136\/bmj-2022-070135","article-title":"Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis","volume":"378","author":"Kechagias","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.vaccine.2023.03.073_b0050","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1080\/21645515.2017.1363133","article-title":"Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine","volume":"13","author":"Adjei Boakye","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.073_b0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21645515.2020.1783952","article-title":"Declining awareness of HPV and HPV vaccine within the general US population","volume":"17","author":"Chido-Amajuoyi","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12885-018-4198-8","article-title":"Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia","volume":"18","author":"Touch","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.073_b0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/07448481.2018.1484364","article-title":"Knowledge and perception of female nursing students about human papillomavirus (HPV), cervical cancer, and attitudes toward HPV vaccination","volume":"67","author":"D\u00f6nmez","year":"2019","journal-title":"J Am Coll Health"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0070","article-title":"Assessment of Knowledge, Attitudes, and Propensity towards HPV Vaccine of Young Adult Students in Italy","volume":"8","author":"Trucchi","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.03.073_b0075","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IDR.S178381","article-title":"Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus","volume":"12","author":"Toh","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"9719","key":"10.1016\/j.vaccine.2023.03.073_b0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(09)62029-8","article-title":"Gardasil: from bench, to bedside, to blunder","volume":"375","author":"Bach","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12889-017-4567-2","article-title":"Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States","volume":"18","author":"Henry","year":"2017","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.073_b0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1475-6773.00174","article-title":"Disparities in adolescent health and health care: does socioeconomic status matter?","volume":"38","author":"Newacheck","year":"2003","journal-title":"Health Serv Res"},{"issue":"8","key":"10.1016\/j.vaccine.2023.03.073_b0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.vaccine.2019.12.030","article-title":"Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid","volume":"38","author":"Inguva","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.073_b0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/07448481.2015.1031237","article-title":"Disparities in Human Papillomavirus Vaccine Literacy and Vaccine Completion Among Asian American Pacific Islander Undergraduates: Implications for Cancer Health Equity","volume":"63","author":"Lee","year":"2015","journal-title":"J Am Coll Health"},{"issue":"6","key":"10.1016\/j.vaccine.2023.03.073_b0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jadohealth.2013.07.002","article-title":"Racial disparities in human papillomavirus vaccination: does access matter?","volume":"53","author":"Gelman","year":"2013","journal-title":"J Adolesc Health"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0110","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2023.03.073_b0115","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.5888\/pcd16.180447","article-title":"Rural-Urban and Racial\/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010\u20132014","volume":"16","author":"Yu","year":"2019","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.03.073_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172548","article-title":"Recent trends in racial and regional disparities in cervical cancer incidence and mortality in the United States","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.03.073_b0125","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez MA, Ward LM, P\u00e9rez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med. 3(3):235-241. 10.1370\/afm.291.","DOI":"10.1370\/afm.291"},{"issue":"41","key":"10.1016\/j.vaccine.2023.03.073_b0130","article-title":"An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia. Gynecol","volume":"15","author":"Boyles","year":"2022","journal-title":"Oncol Rep"},{"issue":"14","key":"10.1016\/j.vaccine.2023.03.073_b0135","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1002\/cam4.3192","article-title":"Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns","volume":"9","author":"Fokom Domgue","year":"2020","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.vaccine.2023.03.073_b0140","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.vaccine.2009.12.063","article-title":"Predictors of HPV vaccine uptake among women aged 19\u201326: importance of a physician\u2019s recommendation","volume":"29","author":"Rosenthal","year":"2011","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2023.03.073_b0145","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV Vaccination and the Risk of Invasive Cervical Cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.03.073_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10900-019-00719-5","article-title":"Perceived Barriers and Trends in HPV Vaccination via Patient Survey Responses at Kalamazoo, Michigan\u2019s Federally-Qualified Health Center","volume":"45","author":"VanderVeen","year":"2020","journal-title":"J Community Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:26:35Z","timestamp":1759404395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X2300378X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus vaccination receipt and provider counseling rates among high-risk patients","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}